PofoliaShared via Pofolia

Communications Biology· 2026Q1

Organelle associations and metabolic rewiring of size-defined hepatic lipid droplets

Qiumin Liao, Xiaochuan Fu, Yang Wang, Yilu Xu et al.

Short summary

Hepatic lipid droplets (LDs) are sorted by size and organelle association, revealing large LDs (L-LDs) as mitochondrion-coupled fueling hubs and small LDs (S-LDs) as lysosome-coupled trafficking/turnover hubs.

AI-generated from the title and abstract; the full text is not read.

Key points

  • A fractionation workflow resolves hepatic LDs by size and organelle association, defining intrinsic LD proteomes.
  • Large LDs (L-LDs) are mitochondrion-coupled 'fueling hubs', while small LDs (S-LDs) are lysosome-coupled 'trafficking and turnover hubs'.
  • Metabolic stress (fasting/steatosis) induces lysosomal machinery recruitment to S-LDs and mitochondrial recruitment to both LD pools.
  • A 'parallel programs' model is proposed where S-LD-associated mitochondria power degradative machinery.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract Lipid droplet (LD) size is a key determinant of hepatic lipid metabolism, yet the molecular programming routing size-defined subpopulations to distinct fates remains unclear. Here we show that a fractionation workflow resolves hepatic LDs by size and organelle association, defining a high-confidence intrinsic LD proteome. Moreover, comparative proteomics of fasted livers reveals a clear ‘division of labor’: Large LDs (L-LDs) function as specialized mitochondrion-coupled ‘putative fueling hubs’, whereas small LDs (S-LDs) serve as lysosome-coupled ‘putative trafficking and turnover hubs’. This interaction map is highly plastic; metabolic stress (fasting or steatosis) triggers a programmatic remodeling where lysosomal machinery is inducibly recruited to S-LDs. Crucially, in vivo stress recruits mitochondria to both pools, supporting a ‘parallel programs’ model where S-LD-associated mitochondria are hypothesized to power the energy-intensive degradative machinery. These findings establish that metabolic state leverages LD size to direct organelle partnerships, nominating the small-LD lysosomal axis as a critical regulatory node in metabolic-associated fatty liver disease (MAFLD).

The authors' abstract, as published at the source. Communications Biology, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Biochemistry (Biochemistry, Genetics and Molecular Biology)

BiochemistryBiochemistry, Genetics and Molecular Biology